W. Blumenschein

Immunology · 2002–2019

A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 15 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 166 citations into it; #269 of 2,160 by trust here, #80 by citations

Whom W. Blumenschein trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Cua

Who trusts W. Blumenschein overall

1. Ming O. Li
2. Wenjun Ouyang
3. Wan-Wan Lin
4. Y. Lee
5. M. McGeachy
6. R. Flavell
7. L. Harrington
8. Nora Koutruba
9. Christopher A. Hunter

Papers from W. Blumenschein's perspective

Ordered by how strongly the researchers W. Blumenschein trusts endorse each paper. Same corpus, a different order for every researcher.

1. Microbial Lipopeptides Induce the Production of IL-17 in Th Cells1 (Journal of Immunology)
2. Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17*
3. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1
4. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
5. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
6. High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism1 (Journal of Immunology)
7. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. (Immunity)
8. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells (Science)
9. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells (Nature Immunology)
10. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. (Arthritis & Rheumatism)

Their papers

• A Single Dose of Neoadjuvant PD-1 Blockade Predicts Clinical Outcomes in Resectable Melanoma (2019) — 613 citations
• Clinical improvement in psoriasis with specific targeting of interleukin-23 (2015) — 214 citations
• IL-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability (2015) — 712 citations
• Interleukin 23 receptor is essential for terminal differentiation of effector T helper type 17 cells in vivo (2009) — 1,081 citations
• Development, cytokine profile and function of human interleukin 17–producing helper T cells (2007) — 2,200 citations
• TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology (2007) — 1,513 citations
• IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. (2006) — 1,659 citations
• Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. (2006) — 626 citations
• IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis (2006) — 708 citations
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation (2005) — 4,408 citations
• Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation (2003) — 1,857 citations
• IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. (2002) — 1,563 citations